Cite
Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomes.
MLA
Mo, Xiao-Dong, et al. “Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical Outcomes.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 20, no. 12, Dec. 2014, pp. 2023–28. EBSCOhost, https://doi.org/10.1016/j.bbmt.2014.08.023.
APA
Mo, X.-D., Kong, J., Zhao, T., Xu, L.-P., Zhang, X.-H., Liu, D.-H., Wang, Y., Chen, H., Yan, C.-H., Chen, Y.-H., Han, W., Wang, F.-R., Wang, J.-Z., Liu, K.-Y., & Huang, X.-J. (2014). Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 20(12), 2023–2028. https://doi.org/10.1016/j.bbmt.2014.08.023
Chicago
Mo, Xiao-Dong, Jun Kong, Ting Zhao, Lan-Ping Xu, Xiao-Hui Zhang, Dai-Hong Liu, Yu Wang, et al. 2014. “Extramedullary Relapse of Acute Leukemia after Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical Outcomes.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 20 (12): 2023–28. doi:10.1016/j.bbmt.2014.08.023.